Answers are grounded in this paper and cite their sources.
Background: Limited evidence is available regarding preferences of women with uterine fibroids (UF) and treating healthcare providers (HCPs) regarding treatment attributes; this evidence could contribute to patient-centered shared decision-making. The aim of this study was to understand HCP and patient preferences when evaluating pharmaceutical treatments for symptomatic UF, and to identify HCP and patient segments that differ in their preferences. Methods: HCPs involved in UF management and patients diagnosed with UF completed a survey assessing the importance of treatment attributes in the UF therapy choice; an adaptive self-explication method was applied to estimate relative importance (RI), indexed to an average of 100. Attributes with RI >100 or <100 indicated a larger or lesser influence, respectively, in driving treatment choice. A clustering (K-means) algorithm was used to determine HCP and patient segments. Attribute RI was estimated for the overall sample and segments. Segment-specific RI estimates that were >10 points higher or lower than the overall study population mean were considered key differentiating drivers for that segment. Results: In total, 375 HCPs and 300 patients responded to the survey. Four HCP and four patient segments were identified. Healthcare provider segments identified were: "efficacy-focused" (n=99), "safety-focused" (n=97), "convenience-focused" (n=93), and "economics-focused" (n=86). Patient segments identified were: "symptom-relief-driven" (n=127), "information-driven" (n=67), "cost-sensitive and surgery-averse" (n=58), and "risk-averse" (n=48). Conclusion: HCPs and patients consider a variety of factors when assessing uterine fibroid treatments. For HCPs, segmentation may elucidate motivations behind treatment choices, while segmentation of patients into distinct groups, each with specific needs, goals, and behaviors, allows for more tailored care. Understanding treatment decision drivers can support patient-centered shared decision-making by enabling HCPs to recognize patient segments and engage with patients accordingly. Shared decision-making may help optimize UF management by focusing discussions on patients' priorities, increasing patient engagement, and improving health equity.
No takes yet. Share an insight, caveat, or question.
Madueke-Laveaux et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: